pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    JBI-778
    Adenoid Cystic Carcinoma (ACC) Jubilant Therapeutics Inc
  • Phase 2
    JBI-802
    Neuroendocrine Tumors Jubilant Therapeutics Inc
  • Preclinical
    JBTmiR-2
    Coronary Artery Disease (CAD) (Ischemic Heart Disease) Jaan Biotherapeutics Inc
  • Phase 1
← prev
page 112 of 271
next →
Pain89
Neurology1
JBZ-001
Diffuse Large B-Cell Lymphoma
Jabez Biosciences Inc
  • Phase 2
    JCXH-105
    Herpes Zoster (Shingles) Immorna Hangzhou Biotechnology Co Ltd
  • Phase 2
    JCXH-107
    Seasonal Influenza Immorna Hangzhou Biotechnology Co Ltd
  • Phase 2
    JCXH-221
    Coronavirus Disease 2019 (COVID-19) Immorna Hangzhou Biotechnology Co Ltd
  • Preclinical
    JD-004
    Polycystic Kidney Disease J and D Pharmaceuticals LLC
  • JENTADUETO XR
    JENTADUETO XR (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE)
    no indication BOEHRINGER INGELHEIM
  • Phase 2
    JIN-A02
    Non-Small Cell Lung Cancer J Ints Bio Co Ltd
  • Phase 2
    JK-07
    Diastolic Heart Failure (HFpEF) Salubris Biotherapeutics Inc
  • Preclinical
    JLK-247
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Phoenix Nest Inc
  • Phase 1
    JMKX-1899
    Colorectal Cancer HUYA Bioscience International LLC
  • Phase 3
    JNJ-1900
    Head And Neck Squamous Cell Carcinoma (HNSC)$JNJ JOHNSON & JOHNSON
  • Phase 2
    JNJ-2056
    Alzheimer's Disease Johnson & Johnson Innovative Medicine
  • Phase 3
    JNJ-69968054
    Escherichia coli Infections$JNJ JOHNSON & JOHNSON
  • Phase 2
    JNS-101
    Friedreich Ataxia$JUNS JUPITER NEUROSCIENCES, INC.
  • Phase 1
    JNS-107
    MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic A…$JUNS JUPITER NEUROSCIENCES, INC.
  • Preclinical
    JNS-108
    Mild Cognitive Impairment$JUNS JUPITER NEUROSCIENCES, INC.
  • Phase 1
    JNS-115
    Parkinson's Disease$JUNS JUPITER NEUROSCIENCES, INC.
  • JOURNAVX
    JOURNAVX (SUZETRIGINE)
    1 INDICATIONS AND USAGE JOURNAVX is indicated for the tre…$VERX Vertex, Inc.
  • JOYEAUX
    JOYEAUX (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)
    no indication XIROMED
  • Phase 1
    JPH-034
    Glioma J-Pharma Co Ltd
  • Preclinical
    JR-220
    Alcohol Use Disorder (AUD) Naprogenix Inc
  • Preclinical
    JV-MD2 (Omega-3)
    Retinopathy Of Prematurity Jenivision Inc (Inactive)
  • Phase 2
    JWATM-204
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 1
    JZP-3507
    Ependymoma$JAZZ Jazz Pharmaceuticals plc
  • Phase 1
    JZP-898
    Gastroesophageal (GE) Junction Carcinomas$JAZZ Jazz Pharmaceuticals plc
  • Marketed
    Jadenu
    Jadenu (deferasirox)
    Thalassemia$NVS NOVARTIS AG
  • Phase 2
    JadiCell ARDS
    Acute Respiratory Distress Syndrome Breathe Biologics Inc